19-49836226-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000312865.10(MED25):c.1966C>A(p.Pro656Thr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,611,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P656L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000312865.10 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MED25 | NM_030973.4 | c.1966C>A | p.Pro656Thr | missense_variant, splice_region_variant | 17/18 | ENST00000312865.10 | NP_112235.2 | |
MED25 | NM_001378355.1 | c.1966C>A | p.Pro656Thr | missense_variant, splice_region_variant | 17/18 | NP_001365284.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MED25 | ENST00000312865.10 | c.1966C>A | p.Pro656Thr | missense_variant, splice_region_variant | 17/18 | 1 | NM_030973.4 | ENSP00000326767 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000946 AC: 23AN: 243146Hom.: 0 AF XY: 0.000120 AC XY: 16AN XY: 133162
GnomAD4 exome AF: 0.000130 AC: 190AN: 1459724Hom.: 0 Cov.: 32 AF XY: 0.000138 AC XY: 100AN XY: 726138
GnomAD4 genome AF: 0.000138 AC: 21AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74360
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 12, 2022 | This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 656 of the MED25 protein (p.Pro656Thr). This variant is present in population databases (rs199761611, gnomAD 0.02%). This missense change has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 26257172, 30039206). ClinVar contains an entry for this variant (Variation ID: 329887). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Tip-toe gait Pathogenic:1
Pathogenic, flagged submission | clinical testing | Practice for Gait Abnormalities, David Pomarino, Competency Network Toe Walking c/o Practice Pomarino | Jan 11, 2022 | In the molecular genetic analysis, the variant c.1966C>A p. (Pro656Thr) can be detected. The amino acid substitution is in a region responsible for binding of the retinoic acid receptor. The variant has been mentioned in the literature in connection with Charcot-Marie-Tooth disease [Gonzaga-Jauregui (2015) Cell Rep 12: 1169]. The authors describe a patient in whom the above variant in combination with a second heterozygous MED25 variant (c.1004C>T p.(Ala335Val)) was detected. However, the rating was the second variant Ala335Val was later withdrawn by the authors as a "causal pathogen" in another family with frequent occurrence of CMT [Leal (2018) Neurogenetics 19: 215]. Hereditary motor sensory neuropathy (HMSN), also known as Charcot-Marie-Tooth Disease (CMT), is the most commonly inherited peripheral polyneuropathy. It constitutes a group of inherited, progressive, motor and sensory peripheral nerve disorders with properties of demyelination, axonal degeneration, or both. It is classified by clinical characteristics, modes of inheritance, electrophysiologic features, metabolic defects, and specific gene markers. Our patients all walk on tiptoe, so they show similar symptoms. When we genetically test them with our toe walking panel, we find that around 90 per cent of them have a genetic variant that explains their toe walking. These can be assigned, for example, to the area of myopathies (such as variants of the COL6A3 gene), the area of hereditary neuropathies (such as variants of the KMT2C gene) or the area of metabolic diseases (such as variants of the PYGM gene). In a smaller group of patients with almost identical symptoms, no abnormality is found in the genes of our panel, but spastic paraplegia can be detected. In another small group of our toe walkers, no abnormalities can be detected in the genes analysed in our toe walking panel, nor do they suffer from spastic paraplegia, as is also the case with healthy children. In contrast to these, however, they show a tiptoe gait. These patients suffer from infantile cerebral palsy, in which toe walking can also be observed. - |
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Molecular Genetics Laboratory, London Health Sciences Centre | - | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at